Personal profile
Research Interests
- neurodegenerative diseases
- pain
- dermatology
Education/Academic qualification
Master, Organic Chemistry, Aix-Marseille Université
Doctorate, Organic Chemistry, Aix-Marseille Université
Bachelor, Chemistry
External positions
CEO and co-founder, DermaXon LLC
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 11 Sustainable Cities and Communities
Fingerprint
Dive into the research topics where Philippe Diaz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 40 Article
-
Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage
Birru, B., Veit, J. G. S., Arrigali, E. M., Van Tine, J., Barrett-Catton, E., Tonnerre, Z., Diaz, P. & Serban, M. A., 2024, In: Frontiers in Pharmacology. 15, p. 1355283 1355283.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Cannabinoids activate the insulin pathway to modulate mobilization of cholesterol in C. elegans
Hernandez-Cravero, B., Gallino, S., Florman, J., Vranych, C., Diaz, P., Elgoyhen, A. B., Alkema, M. J. & de Mendoza, D., Nov 8 2022, In: PLoS Genetics. 18, 11, e1010346.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
Horne, E. A., Diaz, P., Cimino, P. J., Jung, E., Xu, C., Hamel, E., Wagenbach, M., Kumasaka, D., Wageling, N. B., Azorín, D. D., Winkler, F., Wordeman, L. G., Holland, E. C. & Stella, N., Jan 1 2021, In: Neuro-Oncology Advances. 3, 1, vdaa165.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders
Veit, J. G. S., De Glas, V., Balau, B., Liu, H., Bourlond, F., Paller, A. S., Poumay, Y. & Diaz, P., Jan 2021, In: Journal of Investigative Dermatology. 141, 1, p. 72-83.e6Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations -
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders
Veit, J. G. S., Poumay, Y., Mendes, D., Kreitinger, J., Walker, L., Paquet, A., Menigot, C., Zolezzi, F., Paller, A. S. & Diaz, P., Jun 2021, In: Skin Health and Disease. 1, 2, e22.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations